Sign in

CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411458152
Phone
206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
Open-market buys, last 90 days
$72,488
in 2 filings
Open-market sales, last 90 days
$1,622,534
in 5 filings

Net −$1,550,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lantheus Alpha Therapy, LLC −$1.3M 10% owner sold 3% of stake
  2. Lantheus Holdings, Inc. −$357K 10% owner sold <1% of stake
  3. Spoor Johan M. +$38K Chief Executive Officer 1 filing
  4. Puhlmann Markus +$35K Chief Medical Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2019-06-18 Austin Mark John Controller/Prin Fin&Acct Offic Grant or award · Stock Options (right to buy) +50,000 225,000
2019-06-18 Woods Lori A CEO Grant or award · Stock Options (right to buy) +250,000 600,000
2019-06-18 McCormick Michael W Director Grant or award · Stock Options (right to buy) +30,000 115,000
2019-06-18 Vitale Philip J Director Grant or award · Stock Options (right to buy) +30,000 115,000
2019-06-18 Hoffmann Alan Director Grant or award · Stock Options (right to buy) +30,000 115,000
2019-05-30 Cline Krista Dir. of Operations, Secretary Option exercise +21,900 $0.26 $6K 22,933
2019-05-30 Cline Krista Dir. of Operations, Secretary Option exercise · Stock Options (right to buy) −21,900 197,500
2018-11-20 Hoffmann Alan Director Purchase +25,000 $0.40 $10K 45,000
2018-11-16 Austin Mark John Controller/Prin Fin&Acct Offic Purchase +4,283 $0.40 $2K 16,000
2018-11-16 Cavanagh William COO, CSO Purchase +10,000 $0.40 $4K 10,000
2018-11-15 Woods Lori A Interim CEO Purchase +4,365 $0.40 $2K 129,365
2018-11-15 Woods Lori A Interim CEO Purchase +635 $0.40 $252 130,000
2018-11-14 Woods Lori A Interim CEO Purchase +125,000 $0.40 $50K 125,000
2018-11-13 Austin Mark John Controller/Prin Fin&Acct Offic Purchase +2,452 $0.41 $1K 11,717
2018-11-13 Vitale Philip J Director Purchase +30,000 $0.43 $13K 110,000
2018-07-18 Hoffmann Alan Director Grant or award · Stock Options (right to buy) +25,000 85,000
2018-07-18 Vitale Philip J Director Grant or award · Stock Options (right to buy) +25,000 85,000
2018-07-18 McCormick Michael W Director Grant or award · Stock Options (right to buy) +25,000 85,000
2018-06-26 Hoffmann Alan Director Grant or award · Stock Options (right to buy) +5,000 60,000
2018-06-26 Vitale Philip J Director Grant or award · Stock Options (right to buy) +5,000 60,000

Page 11 of 26 · 504 trades